Femasys (FEMY) announces a partnership with CNY Fertility, a national provider of fertility services across the U.S. CNY Fertility will provide the Company’s FemaSeed intratubal insemination product as an infertility treatment option to patients throughout its network of 11 locations.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys’s Strategic Expansion and Promising Clinical Results Justify Buy Rating
- Femasys secures partnerships for commercialization of FemBloc in Spain
- Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating
- Femasys announces FemBloc delivery system approval in Europe
- Femasys’s FemBloc: A Promising Investment in Permanent Contraceptive Innovation
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue